1416469-17-4

Basic information

• Product Name: {4-[3-(4-chlorophenyl)-2-(4-chlorophenylimino)-4-oxothiazolidin-5-ylidenemethyl]-2-methoxyphenoxy}acetic acid
• CAS NO: 1416469-17-4
• Molecular Weight: 529.4
• Mol File: 1416469-17-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {4-[3-(4-chlorophenyl)-2-(4-chlorophenylimino)-4-oxothiazolidin-5-ylidenemethyl]-2-methoxyphenoxy}acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: {4-[3-(4-chlorophenyl)-2-(4-chlorophenylimino)-4-oxothiazolidin-5-ylidenemethyl]-2-methoxyphenoxy}acetic acid(1416469-17-4)
• EPA Substance Registry System: {4-[3-(4-chlorophenyl)-2-(4-chlorophenylimino)-4-oxothiazolidin-5-ylidenemethyl]-2-methoxyphenoxy}acetic acid(1416469-17-4)

Safety Data

• Hazardous Substances Data: 1416469-17-4(Hazardous Substances Data)

Upstream product

• 106-47-8 4-chloro-aniline 
• 1220-00-4 1,3-bis(4-chlorophenyl)thiourea 
• 1660-19-1 (4-formyl-2-methoxyphenoxy)acetic acid 
• 23233-43-4 3-(4-chlorophenyl)-2-(4-chlorophenylimino)thiazolidin-4-one 

Relevant articles and documents

Synthesis of novel 4-thiazolidione derivatives as antibacterial agents against drug-resistant Staphylococcus epidermidis

A series of novel substituted 4-thiazolidione derivatives were designed, synthesized, and evaluated in vitro for their antibacterial activities, in comparison with methicillin and ampicillin. Compounds (7d, 7h-k) exhibit good potency in inhibiting the growth of Staphylococcus epidermidis (MIC: 1.57-3.13 μM). Further antibacterial effects of compounds (7d, 7h-k) were investigated using clinical isolates (methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus), in comparison with methicillin and levofloxacin. Compound 7k showed the most potent antibacterial activities among the synthesized compounds.